KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Receivables - Other (2020 - 2024)

Clover Health Investments' Receivables - Other history spans 5 years, with the latest figure at $15.0 million for Q3 2024.

  • For Q3 2024, Receivables - Other rose 1.37% year-over-year to $15.0 million; the TTM value through Sep 2024 reached $15.0 million, up 1.37%, while the annual FY2023 figure was $16.7 million, 29.37% down from the prior year.
  • Receivables - Other reached $15.0 million in Q3 2024 per CLOV's latest filing, down from $21.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $24.3 million in Q1 2023 to a low of $11.4 million in Q4 2020.
  • Average Receivables - Other over 5 years is $18.5 million, with a median of $17.9 million recorded in 2021.
  • Peak YoY movement for Receivables - Other: plummeted 38.77% in 2022, then soared 76.91% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $11.4 million in 2020, then increased by 25.63% to $14.3 million in 2021, then surged by 65.21% to $23.6 million in 2022, then fell by 29.37% to $16.7 million in 2023, then decreased by 10.22% to $15.0 million in 2024.
  • Per Business Quant, the three most recent readings for CLOV's Receivables - Other are $15.0 million (Q3 2024), $21.2 million (Q2 2024), and $22.5 million (Q1 2024).